Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Hayes

Showing results (141-150 of 336) with videos related to

Pageof 34
Sort By:
American Journal of Surgery|July 30, 2003
Sentinel node biopsy prior to neoadjuvant chemotherapyMichael S Sabel, Anne F Schott, Celina G Kleer, et al.
British Journal of Clinical Pharmacology|January 27, 2022
Muscle mass affects paclitaxel systemic exposure and may inform personalized paclitaxel dosingDaniel L Hertz, Li Chen, N Lynn Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trialVered Stearns, Rebecca Slack, Nancy Greep, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2023
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline UpdateAntonio C Wolff, Mark R Somerfield, Mitchell Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumorsTimothy D Gilligan, Jerome Seidenfeld, Ethan M Basch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancerVered Stearns, Baljit Singh, Theodore Tsangaris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activityVered Stearns, Ann Gallagher, Celina G Kleer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapyCarmen J Allegra, J Milburn Jessup, Mark R Somerfield, et al.
Archives of Pathology & Laboratory Medicine|June 12, 2023
Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerAntonio C Wolff, Mark R Somerfield, Mitchell Dowsett, et al.
Journal of Clinical Pharmacology|December 17, 2011
Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozoleLauren Nicole Bell, Anne Thi Phuong Nguyen, Lang Li, et al.
Pageof 34

Showing results (141-150 of 336) with videos related to

Sort By:
Pageof 34
American Journal of Surgery|July 30, 2003
Sentinel node biopsy prior to neoadjuvant chemotherapyMichael S Sabel, Anne F Schott, Celina G Kleer, et al.
British Journal of Clinical Pharmacology|January 27, 2022
Muscle mass affects paclitaxel systemic exposure and may inform personalized paclitaxel dosingDaniel L Hertz, Li Chen, N Lynn Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trialVered Stearns, Rebecca Slack, Nancy Greep, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2023
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline UpdateAntonio C Wolff, Mark R Somerfield, Mitchell Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumorsTimothy D Gilligan, Jerome Seidenfeld, Ethan M Basch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancerVered Stearns, Baljit Singh, Theodore Tsangaris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activityVered Stearns, Ann Gallagher, Celina G Kleer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapyCarmen J Allegra, J Milburn Jessup, Mark R Somerfield, et al.
Archives of Pathology & Laboratory Medicine|June 12, 2023
Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerAntonio C Wolff, Mark R Somerfield, Mitchell Dowsett, et al.
Journal of Clinical Pharmacology|December 17, 2011
Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozoleLauren Nicole Bell, Anne Thi Phuong Nguyen, Lang Li, et al.
Pageof 34